Bergua Burgués, Juan Miguel | Hematología y Hemoterapia |

Resultados: 244
Tipo Título / Nombre Autor(es) Año
Lack of prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative, b-cell precursor all treated according to MRD oriented protocols Ribera JM, Morgades M, Ciudad J, Montesinos P, Tormo M, González Campos J, Martino R, Vives S, Gil C, Mercadal S, Bernal T, Escoda L, García Boyero R, Guárdia R, Barba P, Amigo M, Bermúdez A, Cladera A, Moreno M, Martínez P Hernández Rivas JM, Font P, Bergua J, Feliu E, Orfao A 2016
Preliminary results of the flugaza trial: a phase iii randomized, open label study comparing azacytidine versus fludarabine and cytarabine (fluga scheme) in elderly patients with newly diagnosed acute myeloid leukemia Vives S, Martínez-Sánchez MD, Bergua J, Algarra L, Herrera Pilar MD, Tormo M, López Lorenzo JL, Ramos F, Falantes JF, Salamero O, Serrano J, Gil C, Amador ML, Lavilla E, Sayas MJ, Olave MT, Vidriales B, Martínez-Cuadrón D, Sanz MA 2016
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies? Sánchez-Correa B, Campos C, Pera A, Bergua JM, Arcos MJ, Bañas H, Casado JG, Morgado S, Duran E, Solana R, Tarazona R 2016
High Correlation Clinical Responses to 1st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test Montesinos P, Ballesteros J, Martinez Cuadrón D, Martínez López J, Serrano J, Pérez de Oteyza J, Fernández P, Rodríguez Macías G, Vidriales MB, Herrera P, Tormo M, Bergua J, García R, Vives S, Fernández MA, Lavilla E, Jiménez S, Péres Simón JA, Simiele A, González A, González BJ, Burgaleta C [et.al] 2015
Assessment of Clinical Differences Between Starting Antimyeloma Treatment at Biological Relapse or at Clinical Relapse: Preliminary Results of an Observational Prospective Registry Gironella M, Bergua J, Fernández de Larrea C, Escalante F, González M, Martínez Chamorro C, López A, Pérez Persona E, Lahuerta JJ, Somilinos N, Soler A, González Y, Suárez Cabrera A, Barez A, Cabañas V, Sampol A, González AP, Giselle Lostaunau , Vilanova D, Alegre A 2015
Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Adult Acute Lymphoblastic Leukemia (ALL) According to Minimal Residual Disease (MRD). P Ribera JM, Morgades M, Ciudad J, Barba P, Martino R, Montesinos P, Vives S, Moreno MJ, Soria B, Cil C, González Campos J, Amigo ML, Novo A, Torno M, Bermudéz A, Serrano A, Bernal T, López A, Bergua J, Escoda L, Martínez P, Alonso N, Mercadas S, Abella E, Cuardia R, Vall-llovera F, Cladera A, Esteve J, García Boyero R, Feliu E, Orfao A 2015
Incidence, Treatment and Prognosis of Patients with Relapsed Burkitt Lymphoma/Leukemia Treated with Specific Chemotherapy or Immunochemotherapy in Spain Pineda A, Sancho JM, García O, Esteve J, Tormo M, Martínez P, Vall-llovera F, Martino R, Montesinos P, González Campos J, Bergua J, Calbacho M, Gil C, Vicent A, Cladera A, Hernández J, Moreno MJ, Serrano A, Alonso N, García R, Barba P, Fernández A, Miralles P, Novo A, Moraleda JM, Hernández JA, Abella E, Sánchez M, López ME, Bernal T, Mateos MC, Lavilla E, Ribera JM 2015
Relationship between Antiphospholipid Syndrome clinical manifestations and multiple positive antiphospholipid antibodies. Sigüenza R, Bermejo N, Casas I, Ibañez F, Bañas MH, Bergua JM, Arcos MJ, Prieto J, Martin-Mateos ML, Cabrera C, Perez-Leal FA 2015
CD38 expression on CD34+ Bone Marrow Cells (BM) as a tool in low grade Myelodysplactics Syndromes (MDS) Sigüenza R, Bañas MH, Casas I, Ibañez F, Bermejo N, Bergua JM, Arcos MJ, Prieto J, Martin-Mateos ML, Cabrera C, Perez-Leal FA 2015
Long-term anticoagulation with dabigatran in patients with severe lactose intolerance Bermejo N, Sigúenza R, Ibañez F, Bañas MH, Casas I, Pérez-Leal FA, Bergua J 2015